N-terminally modified analogues of glucose-dependent insulinotropic polypeptide exhibit improved insulinotropic activity and antihyperglycaemic potential compared with glucagon-like peptide-1 counterparts

V.A. Gault, Brian Green, Brett Greer, Patrick Harriott, P.R. Flatt, F.P.M. O'Harte

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)A177
Number of pages1
Issue numberS2
Publication statusPublished - 2002

Cite this